Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs
Clinical trial NCT00819741 · COMPLETED
Trial details
- NCT number
- NCT00819741
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-11-01
- Enrollment
- 433
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.